PLoS ONE (Jan 2013)

SUMOylation is required for optimal TRAF3 signaling capacity.

  • Sophia Miliara,
  • Kalliopi K Gkouskou,
  • Tyson V Sharp,
  • Aristides G Eliopoulos

DOI
https://doi.org/10.1371/journal.pone.0080470
Journal volume & issue
Vol. 8, no. 11
p. e80470

Abstract

Read online

TNF receptor-associated factors (TRAFs) are multifunctional adaptor proteins involved in temporal and spatial coordination of signals necessary for normal immune function. Here, we report that TRAF3, a TRAF family member with a key role in Toll-like and TNF family receptor signaling and suppressor of lymphomagenesis, is post-translationally modified by the small ubiquitin-related modifier (SUMO). Through yeast two-hybrid and co-immunoprecipitation assays we have identified Ubc9, the SUMO conjugating enzyme, as a novel TRAF3-interacting protein. We show that Ubc9-dependent SUMOylation of TRAF3 modulates optimal association with the CD40 receptor, thereby influencing TRAF3 degradation and non-canonical NF-κB activation upon CD40 triggering. Collectively, our findings describe a novel post-translational modification of a TRAF family member and reveal a link between SUMOylation and TRAF-mediated signal transduction.